Can Clean Rooms Measure Partner Overlap? Yes, With Caveats
How data clean rooms measure audience overlap between partners, what results mean, common pitfalls, and how health brands should set them up.
The short answer
Yes. A data clean room can measure how much two partners' audiences overlap without either party seeing the other's raw records. Each side brings matched identifiers into a controlled environment, the room computes overlap, and only aggregated counts come out. Results depend on match keys, match rates, and how each side defined its audience, so overlap numbers should be read as estimates, with minimum thresholds protecting privacy.
Pharma brands often buy similar audiences from several partners: two HCP data providers, three DSP audience vendors, multiple endemic publishers. Overlap analysis answers a simple question: am I paying for the same people more than once? Clean rooms make that possible without sharing raw data.
How it works
- Each partner prepares its audience file with agreed identifiers (hashed emails, NPIs, household IDs).
- Files are loaded into the clean room.
- The room matches identifiers and counts overlaps.
- Outputs are aggregated: total in A, total in B, in both, in either.
- Minimum thresholds suppress small cells.
See data clean rooms for pharma for setup basics.
What the results show
| Output | Use |
|---|---|
| Overlap count and share | How much A and B share |
| Unique to each | What each partner adds |
| Overlap with your target list | Which partner covers your priority audience |
| Three-way overlap | Whether a third partner adds anything |
Caveats
- Match keys. If A uses hashed emails and B uses household IDs, the room must translate between them, which adds error.
- Match rates. Records that fail to match look unique even when they are not.
- Audience definitions. "Cardiologists" from one partner may include fellows; another may not.
- Timing. Audiences change. Run overlap close to the time you plan to buy.
For HCP audiences
NPI is a strong key, so HCP overlap analysis is often cleaner. Ask each partner for the NPIs they can reach on your list, then compare in a clean room or through a neutral party. The audience overlap analysis guide covers the method.
For consumer health audiences
Consumer health segments involve sensitive data. In a clean room:
- Only aggregated outputs leave.
- Minimum cell sizes prevent singling out individuals.
- Agreements limit use of outputs.
- Privacy review confirms each party's data can be used for this purpose.
Using results
- Drop or renegotiate partners whose audiences are mostly duplicates.
- Shift spend toward unique reach.
- Coordinate frequency across overlapping partners.
Common mistakes
- Treating overlap as exact.
- Comparing partners matched on different keys without adjustment.
- Running overlap once and assuming it holds.
- Forgetting that unmatched records look unique.
Practical takeaway
Before renewing any audience partner, run an overlap check against your other partners on your target list. If more than half its audience is already covered elsewhere, ask what unique value justifies the cost.
Frequently asked questions
What is a data clean room?
A controlled environment where two or more parties can analyze combined data under agreed rules, receiving only approved aggregated outputs.
Why measure partner overlap?
To avoid paying twice for the same audience, to choose partners that add unique reach, and to plan frequency.
Why do overlap results vary?
Different match keys, match rates, and audience definitions change what counts as overlap.
Sources
- IAB Tech Lab, Data Clean Rooms Guidance and Recommended Practices
- HHS, Guidance Regarding Methods for De-identification of PHI
External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.
Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.
New pharma programmatic breakdowns, occasionally
One email when I publish something worth reading. Benchmarks, measurement teardowns, and case studies with the caveats attached. No cadence promises, no reselling your address.
Unsubscribe any time. See the privacy policy.
Working through this decision on a real plan?
I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.